Recent Articles

RAS Pathway v3.0?

| March 24, 2017 | 0 Comments

RAS Pathway v3.0? Defining the most important elements of RAS signaling is an important objective of the NCI RAS Initiative. In a new RAS Dialogue post, advisor Frank McCormick invites community input on version 3.0 of the RAS Pathway.See Original Article Kras and Cancer Metabolism: A Conversation with Carla Martins Our cells ordinarily have two […]

Continue Reading

Colorectal Cancer Incidence Rising in Young Adults: An Interview with Drs. Philip Rosenberg and William Anderson

| March 23, 2017 | 0 Comments

Colorectal Cancer Incidence Rising in Young Adults: An Interview with Drs. Philip Rosenberg and William Anderson Drs. Philip Rosenberg and William Anderson of NCI discuss a recent study on which they were coauthors that reported an increase in colorectal cancer incidence among adults under age 50 in the United States. See Original Article

Continue Reading

Stem-Cell Based Tool May Help Measure Heart Toxicity of Cancer Drugs

| March 21, 2017 | 0 Comments

Stem-Cell Based Tool May Help Measure Heart Toxicity of Cancer Drugs Researchers have used adult stem cells to create a tool for ranking how toxic a group of cancer drugs, called tyrosine kinase inhibitors, are to human heart cells. Such a test could potentially identify toxic side effects earlier in the drug development process.See Original […]

Continue Reading

Researchers Use CRISPR Gene-Editing Tool to Help Turn Immune Cells against Tumors

| March 20, 2017 | 0 Comments

Researchers Use CRISPR Gene-Editing Tool to Help Turn Immune Cells against Tumors Using a new tool for editing genomes, known as CRISPR, researchers have genetically engineered immune cells and improved the ability of these cells to kill cancer cells in mice. See Original Article

Continue Reading

Crizotinib Approval Expanded for Advanced Lung Cancer

| March 17, 2017 | 0 Comments

Crizotinib Approval Expanded for Advanced Lung Cancer The FDA has approved uses of the targeted therapy crizotinib (Xalkori®) for patients with advanced lung cancer whose tumors have alterations in the ROS1 gene.See Original Article The Exceptional Responders Initiative: Welcoming More Cases The initiative is studying tissue, clinical, and genomic data from patients with cancer who […]

Continue Reading

FDA Approves New Use for Lenalidomide in Multiple Myeloma

| March 16, 2017 | 0 Comments

FDA Approves New Use for Lenalidomide in Multiple Myeloma The FDA has approved lenalidomide for use as a maintenance therapy in patients with multiple myeloma who have undergone an autologous stem cell transplant, to help keep the cancer from coming back.See Original Article

Continue Reading

Putting the Cancer Patient Front and Center: An Interview with NCI’s Dr. Paul Jacobsen

| March 14, 2017 | 0 Comments

Putting the Cancer Patient Front and Center: An Interview with NCI’s Dr. Paul Jacobsen NCI’s Dr. Paul Jacobsen discusses NCI’s Healthcare Delivery Research Program and its role in advancing innovative research to improve the delivery of cancer care.See Original Article

Continue Reading

Special Spotlight: Hispanic Heritage Month

| March 12, 2017 | 0 Comments

Special Spotlight: Hispanic Heritage Month CRCHD celebrates Hispanic Heritage Month by highlighting CRCHD-funded research that aims to reduce cancer health disparities in Hispanics and Latinos.See Original Article Grantee Spotlight: Dr. Kolawole Okuyemi – Improving Cervical Cancer Screening Attitudes of African Immigrants and Refugees Dr. Kolawole Okuyumi is studying cervical cancer screening attitudes and behaviors of […]

Continue Reading

Grantee Spotlight: Sunday O. Akintoye, B.D.S., D.D.S., M.S.- Studying the Biology of Bone Cells to Reduce Head and Neck Cancer Treatment Complications

| March 12, 2017 | 0 Comments

Grantee Spotlight: Sunday O. Akintoye, B.D.S., D.D.S., M.S.- Studying the Biology of Bone Cells to Reduce Head and Neck Cancer Treatment Complications Dr. Sunday O. Akintoye, a CRCHD CURE grantee, is studying the behavior of jaw bone stem cells and complications related to cancer treatment. See Original Article Grantee Spotlight: Shawna Hudson, Ph.D. – Helping […]

Continue Reading

Program Spotlight: 2014 Professional Development Workshop Scientific Poster Winners

| March 12, 2017 | 0 Comments

Program Spotlight: 2014 Professional Development Workshop Scientific Poster Winners CRCHD celebrates its 2014 Professional Development Workshop Scientific Poster winnersSee Original Article More Evidence That a Wild-Type KRAS Allele Plays a Role in Cancer Jim Hartley of the RAS Initiative discusses evidence from mouse models that a wild type KRAS allele modulates early selection of Q61L […]

Continue Reading